Overview
Squamous cell carcinoma of the pancreas is a very rare type of pancreatic cancer. Most pancreatic cancers are a type called adenocarcinoma, which starts in gland cells. Squamous cell carcinoma, by contrast, starts in flat, scale-like cells that are not normally found in the pancreas — making this an unusual and poorly understood cancer. It may also be called pancreatic squamous cell carcinoma or primary squamous cell carcinoma of the pancreas. Because it is so rare, it is sometimes grouped under the broader term 'rare exocrine pancreatic tumors.' The pancreas sits deep in the abdomen and plays two main roles: helping digestion and controlling blood sugar. When a tumor grows in the pancreas, it can block nearby structures like the bile duct or digestive tract, causing a range of symptoms. Common symptoms include yellowing of the skin and eyes (jaundice), belly or back pain, unexplained weight loss, poor appetite, nausea, and new-onset diabetes. Because the pancreas is located deep inside the body, symptoms often appear late, when the cancer has already grown or spread. Treatment options are similar to other pancreatic cancers and may include surgery to remove the tumor (if caught early enough), chemotherapy, and radiation therapy. However, because squamous cell carcinoma of the pancreas is so rare, there are no treatment guidelines specifically designed for it, and most care is based on what works for other pancreatic cancers. The outlook is generally poor, especially when the cancer is found at an advanced stage.
Also known as:
Key symptoms:
Yellowing of the skin and whites of the eyes (jaundice)Pain in the upper belly or backUnexplained weight lossLoss of appetiteNausea or vomitingNew or worsening diabetesFatigue and weaknessDark urinePale or greasy stoolsFeeling full quickly when eatingBloating or digestive discomfort
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
6 eventsSutro Biopharma, Inc. — PHASE1
GI Innovation, Inc. — PHASE1, PHASE2
ImmunoGenesis — PHASE1, PHASE2
University of Washington — NA
Taiho Oncology, Inc. — PHASE2
Oncolytics Biotech — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableAlimta
as a single agent for the maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chem…
as a single agent for the maintenance treatment of patients with locally advanced or metastatic, non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesTravel Grants
No travel grants are currently matched to Squamous cell carcinoma of pancreas.
Community
No community posts yet. Be the first to share your experience with Squamous cell carcinoma of pancreas.
Start the conversation →Latest news about Squamous cell carcinoma of pancreas
Disease timeline:
New recruiting trial: A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab
A new clinical trial is recruiting patients for Squamous cell carcinoma of pancreas
New recruiting trial: A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
A new clinical trial is recruiting patients for Squamous cell carcinoma of pancreas
New recruiting trial: Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer
A new clinical trial is recruiting patients for Squamous cell carcinoma of pancreas
New recruiting trial: A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
A new clinical trial is recruiting patients for Squamous cell carcinoma of pancreas
New recruiting trial: A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
A new clinical trial is recruiting patients for Squamous cell carcinoma of pancreas
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Has the cancer spread beyond the pancreas, and what does that mean for my treatment options?,Is surgery possible in my case, and what are the risks and benefits?,Which chemotherapy regimen do you recommend for me, and what side effects should I expect?,Are there any clinical trials I might be eligible for given how rare this cancer type is?,Should I get a second opinion at a major cancer center that specializes in pancreatic cancer?,What palliative care or supportive services are available to help manage my symptoms?,How will we monitor whether the treatment is working?
Common questions about Squamous cell carcinoma of pancreas
What is Squamous cell carcinoma of pancreas?
Squamous cell carcinoma of the pancreas is a very rare type of pancreatic cancer. Most pancreatic cancers are a type called adenocarcinoma, which starts in gland cells. Squamous cell carcinoma, by contrast, starts in flat, scale-like cells that are not normally found in the pancreas — making this an unusual and poorly understood cancer. It may also be called pancreatic squamous cell carcinoma or primary squamous cell carcinoma of the pancreas. Because it is so rare, it is sometimes grouped under the broader term 'rare exocrine pancreatic tumors.' The pancreas sits deep in the abdomen and play
How is Squamous cell carcinoma of pancreas inherited?
Squamous cell carcinoma of pancreas follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Squamous cell carcinoma of pancreas typically begin?
Typical onset of Squamous cell carcinoma of pancreas is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Squamous cell carcinoma of pancreas?
Yes — 2 recruiting clinical trials are currently listed for Squamous cell carcinoma of pancreas on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Squamous cell carcinoma of pancreas?
17 specialists and care centers treating Squamous cell carcinoma of pancreas are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.